MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : MAJOR PHARMACEUTICALS
INNATE PHARMA - ADR

Innate Pharma - ADR

XNAS: IPHA

1.37 -0.14 (-9.27%)

47.91% Fall from 52W High

29,097

XNAS Volume

XNAS 07 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Innate Pharma (ADR) is on 13 May 2026 for the purpose of Innate Pharma SA First Quarter Earnings Result for 2026 See details

Innate Pharma (ADR) - IPHA - stock price prediction, stock price target, analyst ratings from 4 analysts

Innate Pharma (ADR) has a share price target of US$ 6, revenue growth forecast of 246.2%, and profit growth estimate of 40.9% for FY26, based on top 4 analyst calls.

47.91% Fall from 52W High

Innate Pharma (ADR) - IPHA - stock price prediction, stock price target, analyst ratings from 4 analysts

Innate Pharma (ADR) has a share price target of US$ 6, revenue growth forecast of 246.2%, and profit growth estimate of 40.9% for FY26, based on top 4 analyst calls.

Forecaster Screeners